Martin Majer is a Hematology and Oncology doctor at Logan Health Hematology & Oncology. Originally from the Czech Republic, he attended Medical School in Prague at Charles University Faculty of Medicine in 1987. He finished his residency at the University hospital in Prague in 1992. He then came to the U.S. to work with the National Institute of Health (NIH) on diabetes research and to further pursue his studies. He interned from 1996-1997 at Maricopa Medical Center in Phoenix, Arizona, and from 1997-1999, completed his Internal Medicine Residency there with Creighton University School of Medicine. Prior to his hematology-oncology fellowship, he worked as a primary physician for geriatrics and caring for HIV patients in the Bay Area. From 2004-2007, Dr. Majer completed his Medical Oncology Fellowship at the University of Utah in Salt Lake City, Utah. He started work in California in 2007 as a Hematologist and Medical Oncologist, until joining Logan Health in 2022. Dr. Majer has published research on a variety of topics, including Huntington’s disease, retroviruses, diabetes, and cancer. Oncological themes involved biological treatment of renal cell carcinoma, melanoma, pancreatic cancer, colon carcinoma, and breast cancer studies in regard to HER 2 signaling. Outside of work, he enjoys spending time outdoors skiing, hiking, and cycling.
Internal Medicine – American Board of Internal Medicine
Hematology – American Board of Internal Medicine
Medical Oncology – American Board of Internal Medicine
1. Li X., Kuang J., Shen Y., Majer M., Nelson C.C., Parsawar K., Heichman K.A., Kuwada S.K.: The
atypical histone MacroH2A1.2 interacts with HER-2 protein in cancer Cells. J. Biol. Chem. 287: 23171-
23183 2012
2. Samlowski WE, Majer M, Boucher KM, Shrieve AF, Dechet C, Jensen RL, Shrieve DC.: Multidisciplinary
treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer
113: 2539-48 2008
3. Majer M., Samlowski W.E.: Management of metastatic melanoma patients with brain metastases.
Current Oncology Reports 5: 411-6 2007
4. Majer M., Jensen R.J., Shrieve D.C., Watson G.A., Wang M., Leachman S.A., Boucher K.M.,
Samlowski W.E.: Biochemotherapy of metastatic melanoma in patients with and without recently
diagnosed brain metastases. Cancer 110: 1329-37 2007
5. Majer M., Akerley W., Kuwada S.K.: Oncologists’ current opinion on the treatment of colon
carcinoma. Anti-Cancer Agents in Medicinal Chemistry 5: 492-503 2007
6. Majer M., Kuwada S.K.: Targeting the epidermal growth factor receptor (ERBB) family in
gastrointestinal malignancies. In Bamba H, Ota S. ( eds) Recent advances in gastrointestinal
cancerogenesis, 2006:163-180,2006 ISBN: 81-7895-200-9
7. Choueiri T.K., Olencki T., Samlowski W., Florell S., Leachman S., Majer M., Vidimos A.: Unusual
cutaneous malignancies. In Raghavan D., Brecher M.L., Johnson D.H., Meropol N.J., Moots P.L., Rose
P.G. Textbook of uncommon cancer Third Edition 2006: 577-588 ISBN: 0-470-01202-1
8. Majer M., Popov K.M., Harris R.A., Bogardus C., Prochazka M.: Insulin down-regulates pyruvate
dehydrogenase kinase (PDK) RNA: Potential mechanism contributing to increased lipid oxidation in
insulin resistant subjects. Molecular genetics and metabolism 65: 181-186 1998
9. Xia J., Scherer S.W., Cohen P.T., Majer M., Xi T., Norman R.A., Knowler W.C., Bogardus C.,
Prochazka M.: A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes.
Diabetes 47: 1519-1524 1998
10. Mochizuki H, Scherer S.W., Xi T., Nickle D.S., Majer M., Huizenga J.J., Tsui L-C., Prochazka M.:
Human PON2 gene at 7q21.3: cloning, multiple RNA forms, and missense polymorphism in the coding
sequence. Gene 213: 149-157 1998
11. Rowles J.C., Scherer S.W., Xi T., Majer M., Nickle D.C., Rommens J.M., Popov K.M., Harris R.A.,
Riebow N.L., Xia J., Tsiu L-P., Bogardus C., Prochazka M.: Cloning and characterization of PDK4 on
7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J. Biol. Chem. 271:
22376-22382 1996
12. Majer M., Mott D.M., Mochizuki H., Rowles J.C., Pedersen O., Knowler W.C., Bogardus C.,
Prochazka M.: Association of the glycogen synthase locus 19q13 with NIDDM in Pima Indians.
Diabetologia 39: 314-321 1996
13. Majer M., Gerdes B., Zuhlke C., Thies U.: PCR detection of a biallelic polymorphism at D4S43.
Nucl. Asids Res. 20: 926 1992
Logan Health Hematology & Oncology
350 Heritage Way, Suite 1100
Kalispell, MT 59901
p: (406) 752-8900
f: (406) 752-8909
Logan Health Medical Center
This provider subscribes to the Logan Health Financial Assistance Program.
